Recruiting
A Study of LY3041658 in Adults With Hidradenitis Suppurativa
I7P-MC-DSAD - ClinicalTrials.gov - NCT04493502
The reason for this study is to see if the study drug LY3041658 is effective in participants with moderate-to-severe hidradenitis suppurativa (HS).
How long will I be in the trial?
The study will last about 46 weeks and may include up to 22 visits.
Recruiting
A Study of LY3041658 in Adults With Hidradenitis Suppurativa
I7P-MC-DSAD - ClinicalTrials.gov - NCT04493502
The reason for this study is to see if the study drug LY3041658 is effective in participants with moderate-to-severe hidradenitis suppurativa (HS).
How long will I be in the trial?
The study will last about 46 weeks and may include up to 22 visits.
Key Requirements
Age :
18-64
Sex:
All
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Age
18-64
Sex
All
Participants must
Participants must have a diagnosis of HS for at least 6 months
Participants must have HS lesions in at least 2 different anatomic areas
Participants must have inadequate response or intolerance to a 28 day course of oral antibiotics
Participants must have a total count of abscesses and inflammatory nodules greater than or equal to 4
Participants must agree to use a topical antiseptic daily
Participants must agree to stop using topical antibiotics during the study. In certain cases, oral antibiotics will be allowed
Participants must NOT
Participants must not have more than 20 draining fistulae
Participants must not have received any biologic medication (adalimumab, etc.) for the treatment of HS
Participants must not plan to use oral opioids for HS-related pain during the study
Participants must not have uncontrolled depression or suicidal thoughts
Trial Summary
Conditions the trial is for
Hidradenitis Suppurative (Acne Inversa)
What the trial is testing?
LY3041658
Could I receive a Placebo?
no
Enrollment Goal
52
Trial Dates
August 2020 - July 2022
Trial Phase
2
Enter your postal code to find the nearest site
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Age
18-64
Sex
All
Participants must
Participants must have a diagnosis of HS for at least 6 months
Participants must have HS lesions in at least 2 different anatomic areas
Participants must have inadequate response or intolerance to a 28 day course of oral antibiotics
Participants must have a total count of abscesses and inflammatory nodules greater than or equal to 4
Participants must agree to use a topical antiseptic daily
Participants must agree to stop using topical antibiotics during the study. In certain cases, oral antibiotics will be allowed
Participants must NOT
Participants must not have more than 20 draining fistulae
Participants must not have received any biologic medication (adalimumab, etc.) for the treatment of HS
Participants must not plan to use oral opioids for HS-related pain during the study
Participants must not have uncontrolled depression or suicidal thoughts
Trial Summary
Conditions the trial is for
Hidradenitis Suppurative (Acne Inversa)
What the trial is testing?
LY3041658
Could I receive a Placebo?
no
Enrollment Goal
52
Trial Dates
August 2020 - July 2022
Trial Phase
2
Not the right fit? Sign up to receive updates on new trials.
Trial Locations
Hide locations not currently recruiting
Enter your postal code to see sites near you
Hidradenitis Suppurative (Acne Inversa) Resources
